Near-infrared response self-heating microneedle based on recombinant human collagen as well as preparation method and application of near-infrared response self-heating microneedle

The near-infrared responsive self-heating microneedle, composed of recombinant human collagen, hyaluronic acid, and ferroferric oxide, enhances the efficiency of collagen delivery and stability of the suspension.

CN119074587APending Publication Date: 2024-12-06QINGDAO INST OF BIOENERGY & BIOPROCESS TECH CHINESE ACADEMY OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411417820.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-11
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing collagen microneedles face challenges in achieving high biocompatibility and efficient collagen delivery to the skin, with potential issues related to immunity and virality from animal-derived collagen and limited efficacy in promoting collagen regeneration.

Method used

A near-infrared responsive self-heating microneedle is developed using recombinant human collagen, hyaluronic acid, ferroferric oxide, and wool keratin, which heats up under near-infrared irradiation to enhance collagen delivery by increasing local blood circulation and stability of the suspension.

Benefits of technology

The microneedle improves collagen delivery efficiency and safety by utilizing recombinant human collagen, ensuring high biocompatibility and effective skin penetration, while ferroferric oxide enhances thermal response and wool keratin maintains suspension stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119074587A_ABST
    Figure CN119074587A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of cosmetics, and particularly relates to a near-infrared response self-heating microneedle based on recombinant human collagen as well as a preparation method and application of the near-infrared response self-heating microneedle. The prepared micro-needle body is composed of collagen and hyaluronic acid, and the prepared collagen micro-needle is good in formability and solubility, also has a good micro-needle shape, is excellent in mechanical property, and can pierce a skin cuticle; the needle body can be rapidly dissolved after being inserted into the skin, efficient delivery of collagen is achieved, absorption of collagen is promoted, and repair of damaged skin is facilitated. Ferroferric oxide is added to the upper layer of the microneedle, so that spontaneous heating can be realized under near-infrared irradiation, and the collagen delivery efficiency is improved. Wool keratin extracted from alpaca hair is added into a collagen ferroferric oxide aqueous solution in order to prevent ferroferric oxide from gathering and caking when the upper-layer structure is poured, the wool keratin can be adsorbed on the surface of ferroferric oxide, the excellent hydrophilicity of the wool keratin can help the ferroferric oxide to keep dispersed in water, and good application prospects are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of cosmetic products, and in particular relates to a near-infrared responsive self-heating microneedle based on recombinant human collagen, and a preparation method and application thereof. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Collagen is a very important protein that is widely distributed in human skin, bones, muscles and other tissues. It has excellent moisturizing properties, can help the skin stay hydrated, promote the regeneration and repair of skin cells, and has a wide range of applications in the fields of beauty and medical beauty.

[0004] Collagen microneedle beauty is a beauty method that uses microneedle technology to deliver collagen directly to the deep layers of the skin. Specifically, a microneedle roller or microneedle needle is used to deliver a large amount of collagen and nutrients directly to the deep layers of the skin, especially to the mesoderm cells, to improve skin conditions. It can stimulate the regeneration of collagen in the skin, thereby repairing damaged skin tissue and improving skin quality.

[0005] Collagen is an important component of the skin, which can effectively lock in moisture and maintain skin elasticity. Collagen microneedles can lock in moisture and replenish water in layers, making the skin moisturized and shiny. Collagen microneedles can stimulate the regeneration of collagen, improve fine lines and wrinkles, and make the skin firmer and more elastic. In addition, collagen microneedles can also promote skin metabolism, remove aging cuticles, and make the skin whiter, tenderer and smoother.

[0006] Therefore, obtaining a collagen microneedle with high biocompatibility and the ability to further improve collagen delivery efficiency is an issue that researchers in this field urgently need to address. Summary of the invention

[0007] In response to the needs of the prior art, the purpose of the present invention is to provide a near-infrared responsive self-heating microneedle based on recombinant human collagen and its preparation method and application. The microneedle prepared by the present invention is used in conjunction with a near-infrared lamp to self-heat, thereby promoting local blood circulation and improving the collagen delivery efficiency, and has a high application value.

[0008] Specifically, the present invention provides the following technical solutions:

[0009] In a first aspect, the present invention provides a near-infrared responsive self-heating microneedle based on recombinant human collagen, which comprises recombinant human collagen and hyaluronic acid; the amino acid sequence of the recombinant human collagen is shown in SEQ ID NO: 1.

[0010] Preferably, the microneedle comprises a microneedle upper structure and a needle body as a microneedle upper support layer; the materials involved in the needle body include recombinant human collagen and hyaluronic acid; the materials involved in the microneedle upper structure include ferrosoferric oxide and wool keratin.

[0011] Preferably, the method for preparing the recombinant human collagen comprises: transforming the pet28a-rCol plasmid carrying the amino acid sequence of the recombinant human collagen (the target amino acid sequence) into E. coli BL21 competent cells, preparing the BL21 / pet28a-rCol strain seed liquid, inoculating in a fermenter, inducing, and fermenting to obtain the fermentation liquid; collecting the bacterial cells, high-pressure homogenizing and crushing, and centrifuging to obtain the bacterial supernatant; and purifying by nickel ion affinity chromatography to obtain the target protein.

[0012] The second aspect of the present invention provides a method for preparing the above-mentioned near-infrared responsive self-heating microneedle based on recombinant human collagen, which specifically comprises the following steps:

[0013] S1, mixing the hyaluronic acid solution and the recombinant human collagen solution to prepare a microneedle raw material solution;

[0014] S2, adding the microneedle raw material liquid into the mold, and performing vacuum drying, degassing, curing, and demolding to obtain the needle body;

[0015] S3, adding alpaca wool to an aqueous solution containing urea, sodium dodecyl sulfate (SDS) and dithiothreitol (DTT), heating and reacting to obtain wool keratin;

[0016] S4, adding wool keratin, hyaluronic acid and recombinant human collagen to the aqueous solution containing ferroferric oxide particles, adding the mixed reaction solution to the mold, and performing vacuum drying, degassing, curing and demolding to obtain the microneedle upper structure;

[0017] S5. Assemble the needle body and the microneedle upper structure together to obtain the microneedle material.

[0018] Preferably, in step S1, the mass ratio of the hyaluronic acid to the recombinant human collagen is 1:1 to 1:3.

[0019] Preferably, in step S1, the concentration of the hyaluronic acid solution is 10-15 mg / mL, and the concentration of the recombinant human collagen solution is 10-30 mg / mL.

[0020] Further preferably, the concentration of the hyaluronic acid solution is 15 mg / mL.

[0021] Preferably, in step S1, the mixing method is: first prepare a hyaluronic acid solution and heat it at 65°C to 85°C to dissolve it, then perform vacuum drying and degassing treatment, wait until the temperature drops to 20°C to 30°C, add recombinant human collagen solution, perform vacuum drying and degassing treatment, and obtain a microneedle raw material solution.

[0022] More preferably, the pressure of the vacuum drying and degassing treatment is 0.1 kPa and the temperature is 25°C.

[0023] Preferably, in step S2, the pressure of the vacuum drying and degassing is 0.08 to 0.15 kPa, and the temperature is -15 to -25°C; further preferably, the pressure of the vacuum drying and degassing is 0.1 kPa, and the temperature is -20°C.

[0024] Preferably, in step S2, the curing temperature is -15 to -25°C and the curing time is 4 to 6 hours; further preferably, the curing temperature is -20°C and the curing time is 5 hours.

[0025] Preferably, in step S3, the mass ratio of urea, sodium dodecyl sulfate (SDS) and dithiothreitol (DTT) is 22-25:1.9-2.5:0.8-1.2.

[0026] Further preferably, the mass ratio of urea, sodium dodecyl sulfate (SDS) and dithiothreitol (DTT) is 24.9:2.2:1.

[0027] Preferably, in step S3, the alpaca wool is added thereto after being treated with an organic solvent, and the specific operation is: firstly soak the alpaca wool in acetone for 15 to 24 hours, then treat it with ethanol for 24 to 48 hours to remove grease, and then wash it with deionized water.

[0028] Preferably, in step S3, the temperature of the heating reaction is 50-70°C, and the time is 8-15 hours; further preferably, the temperature of the heating reaction is 60°C, and the time is 12 hours.

[0029] Preferably, in step S3, the solution after the heating reaction is filtered, the filtrate is dialyzed in water for 60 to 72 hours, and the wool keratin is collected by freeze-drying.

[0030] Preferably, in step S4, the ferrosoferric oxide particles are added to water at 0.01 wt % to prepare a suspension; the mass volume ratio of the suspension to wool keratin is 1 mL:10 mg.

[0031] Preferably, in step S4, the concentration of the hyaluronic acid solution is 10-15 mg / mL, and the concentration of the recombinant human collagen solution is 10-30 mg / mL.

[0032] Further preferably, the concentration of the hyaluronic acid solution is 15 mg / mL.

[0033] Preferably, in step S4, the pressure of the vacuum drying and degassing is 0.08 to 0.15 kPa, and the temperature is -15 to -25°C; further preferably, the pressure of the vacuum drying and degassing is 0.1 kPa, and the temperature is -20°C.

[0034] Preferably, in step S4, the curing temperature is -15 to -25°C and the curing time is 4 to 6 hours; further preferably, the curing temperature is -20°C and the curing time is 5 hours.

[0035] Preferably, in step S5, during the bonding and assembly, a small amount of water is added to moisten the interface to ensure a close fit.

[0036] The third aspect of the present invention provides the use of the near-infrared responsive self-heating microneedles based on recombinant human collagen described in the first aspect in the preparation of beauty and skin care products, pharmaceutical products, and medical device products.

[0037] The beneficial effects achieved by one or more technical solutions of the present invention are as follows:

[0038] (1) The present invention provides a microneedle made of recombinant human collagen. Compared with collagen extracted from animals, recombinant human collagen can avoid problems such as immunity and virality.

[0039] (2) Compared with traditional microneedles, the present invention adds ferroferric oxide to the upper layer of the microneedles, and utilizes the photothermal effect of ferroferric oxide to increase the local temperature under near-infrared irradiation, thereby promoting blood circulation and significantly improving the delivery effect of collagen.

[0040] (3) Ferroferric oxide has good biocompatibility and is widely used in a variety of medical materials. In the present invention, ferroferric oxide does not directly contact the skin, further ensuring the safety of the material.

[0041] (4) The aqueous suspension of ferroferric oxide particles may have problems such as sedimentation and aggregation. To avoid this phenomenon, the present invention adds wool keratin to the ferroferric oxide suspension. Wool keratin can be adsorbed on the surface of ferroferric oxide. Its excellent hydrophilicity can help ferroferric oxide remain dispersed in water and improve the stability of the suspension. Compared with other surfactants, wool keratin has significantly better biocompatibility, ensuring material safety. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1The morphology of the near-infrared responsive self-heating microneedle based on recombinant human collagen prepared in Example 1 of the present invention;

[0043] Figure 2 Mechanical properties characterization-compression test of the near-infrared responsive self-heating microneedles based on recombinant human collagen prepared in Examples 1 to 3 of the present invention;

[0044] Figure 3 The swelling test of the recombinant human collagen near-infrared responsive self-heating microneedles prepared in Examples 1 to 3 of the present invention in PBS;

[0045] Figure 4 An L929 cell proliferation test was conducted on the extract of the recombinant human collagen near-infrared responsive self-heating microneedles prepared in Example 1 of the present invention;

[0046] Figure 5 This is a test of the Masson staining results of the skin treated with the near-infrared responsive self-heating microneedles based on recombinant human collagen prepared in Example 1 of the present invention. DETAILED DESCRIPTION

[0047] The present invention is described in detail below in conjunction with specific drawings and embodiments. The examples described below are only preferred embodiments of the present invention. It should be noted that the following description is only for the purpose of explaining the present invention and does not limit the present invention in any form. Any simple modification, equivalent changes and modifications made to the embodiments according to the technical essence of the present invention are within the scope of the technical solution of the present invention.

[0048] As mentioned above, collagen microneedle beauty is a beauty method that uses microneedle technology to deliver collagen directly to the deep layers of the skin. It can stimulate the regeneration of collagen in the skin, thereby repairing damaged skin tissue, improving skin quality, and promoting skin metabolism, removing aged keratin, and making the skin fairer and smoother. Therefore, obtaining a collagen microneedle with high biocompatibility and further improving the efficiency of collagen delivery is an urgent problem that researchers in this field need to solve.

[0049] The first typical embodiment of the present invention provides a near-infrared responsive self-heating microneedle based on recombinant human collagen, characterized in that it includes recombinant human collagen and hyaluronic acid; the amino acid sequence of the recombinant human collagen is shown in SEQ ID NO: 1.

[0050] In one or more embodiments of this embodiment, the microneedle includes a microneedle upper layer structure and a needle body serving as a microneedle upper layer support layer; the materials involved in the needle body include recombinant human collagen and hyaluronic acid; the materials involved in the microneedle upper layer structure include ferrosoferric oxide and wool keratin.

[0051] In one or more examples of this implementation, the method for preparing the recombinant human collagen protein comprises: transforming the pet28a-rCol plasmid carrying the amino acid sequence of the recombinant human collagen protein (target amino acid sequence) into E. coli BL21 competent cells, preparing the BL21 / pet28a-rCol strain seed liquid, inoculating in a fermenter, inducing, and fermenting to obtain the fermentation liquid; collecting the bacterial cells, high-pressure homogenizing and crushing, and centrifuging to obtain the bacterial supernatant; and purifying by nickel ion affinity chromatography to obtain the target protein.

[0052] A second typical embodiment of the present invention provides a method for preparing the above-mentioned near-infrared responsive self-heating microneedle based on recombinant human collagen, which specifically comprises the following steps:

[0053] S1, mixing the hyaluronic acid solution and the recombinant human collagen solution to prepare a microneedle raw material solution;

[0054] S2, adding the microneedle raw material liquid into the mold, and performing vacuum drying, degassing, curing, and demolding to obtain the needle body;

[0055] S3, adding alpaca wool to an aqueous solution containing urea, sodium dodecyl sulfate (SDS) and dithiothreitol (DTT), heating and reacting to obtain wool keratin;

[0056] S4, adding wool keratin, hyaluronic acid and recombinant human collagen to the aqueous solution containing ferroferric oxide particles, adding the mixed reaction solution to the mold, and performing vacuum drying, degassing, curing and demolding to obtain the microneedle upper structure;

[0057] S5. Assemble the needle body and the microneedle upper structure together to obtain the microneedle material.

[0058] In one or more examples of this implementation mode, in step S1, the mass ratio of the hyaluronic acid to the recombinant human collagen is 1:1 to 1:3.

[0059] In one or more examples of this embodiment, in step S1, the concentration of the hyaluronic acid solution is 10-15 mg / mL, and the concentration of the recombinant human collagen solution is 10-30 mg / mL.

[0060] In one or more examples of this embodiment, the concentration of the hyaluronic acid solution is 15 mg / mL.

[0061] In one or more examples of this embodiment, in step S1, the mixing method is: first prepare a hyaluronic acid solution and heat it at 65°C to 85°C to dissolve it, then perform vacuum drying and degassing treatment, and wait until the temperature drops to 20°C to 30°C.

[0062] C, add recombinant human collagen solution and perform vacuum drying and degassing treatment to obtain microneedle raw material solution.

[0063] In one or more examples of this embodiment, the pressure of the vacuum drying and degassing treatment is 0.1 kPa and the temperature is 25°C.

[0064] In one or more examples of this embodiment, in step S2, the pressure of the vacuum drying and degassing is 0.08 to 0.15 kPa, and the temperature is -15 to -25°C; further preferably, the pressure of the vacuum drying and degassing is 0.1 kPa, and the temperature is -20°C.

[0065] In one or more examples of this implementation mode, in step S2, the curing temperature is -15 to -25°C and the curing time is 4 to 6 hours; more preferably, the curing temperature is -20°C and the curing time is 5 hours.

[0066] In one or more examples of this implementation mode, in step S3, the mass ratio of urea, sodium dodecyl sulfate (SDS) and dithiothreitol (DTT) is 22-25:1.9-2.5:0.8-1.2.

[0067] In one or more examples of this embodiment, the mass ratio of urea, sodium dodecyl sulfate (SDS) and dithiothreitol (DTT) is 24.9:2.2:1.

[0068] In one or more embodiments of this implementation mode, in step S3, the alpaca wool is added thereto after being treated with an organic solvent. The specific operation is: first, the alpaca wool is soaked in acetone for 15 to 24 hours, then treated with ethanol for 24 to 48 hours to remove grease, and then washed with deionized water.

[0069] In one or more examples of this embodiment, in step S3, the temperature of the heating reaction is 50-70°C, and the time is 8-15 hours; more preferably, the temperature of the heating reaction is 60°C, and the time is 12 hours.

[0070] In one or more examples of this embodiment, in step S3, the solution after the heating reaction is filtered, the filtrate is dialyzed in water for 60 to 72 hours, and the wool keratin is collected by freeze-drying.

[0071] In one or more examples of this implementation mode, in step S4, the ferrosoferric oxide particles are added into water at 0.01 wt % to prepare a suspension; the mass volume ratio of the suspension to the wool keratin is 1 mL:10 mg.

[0072] In one or more examples of this embodiment, in step S1, the concentration of the hyaluronic acid solution is 10-15 mg / mL, and the concentration of the recombinant human collagen solution is 10-30 mg / mL.

[0073] In one or more examples of this embodiment, the concentration of the hyaluronic acid solution is 15 mg / mL.

[0074] In one or more examples of this embodiment, in step S4, the pressure of the vacuum drying and degassing is 0.08 to 0.15 kPa, and the temperature is -15 to -25°C; further preferably, the pressure of the vacuum drying and degassing is 0.1 kPa, and the temperature is -20°C.

[0075] In one or more examples of this implementation mode, in step S4, the curing temperature is -15 to -25°C and the curing time is 4 to 6 hours; more preferably, the curing temperature is -20°C and the curing time is 5 hours.

[0076] In one or more examples of this implementation mode, in step S5, during the bonding and assembly, a small amount of water is added to the interface to moisten it to ensure a close fit.

[0077] A third typical embodiment of the present invention provides an application of the above-mentioned near-infrared responsive self-heating microneedle based on recombinant human collagen in the preparation of beauty and skin care products, pharmaceutical products, and medical device products.

[0078] The present invention will be further described in detail below in conjunction with specific embodiments. It should be noted that the specific embodiments are intended to explain the present invention rather than to limit it.

[0079] Example 1 :This embodiment provides a near-infrared responsive self-heating microneedle based on recombinant human collagen and a preparation method thereof

[0080] (I) Preparation method of recombinant human collagen

[0081] ① Obtaining the amino acid sequence of recombinant human collagen, the sequence is obtained by splicing the active sequence in type III collagen, and the amino acid sequence is shown in SEQ ID NO: 1;

[0082] ② The pet28a-rCol plasmid with the target amino acid sequence (SEQ ID NO: 1) was transformed into E. coli BL21 competent cells to prepare BL21 / pet28a-rCol strain seed solution, which was inoculated in a fermenter, induced, and fermented to obtain a fermentation broth. The cells were collected, crushed by high-pressure homogenization, and centrifuged to obtain the cell supernatant. The target protein was purified by nickel ion affinity chromatography.

[0083] (II) Preparation of microneedle body

[0084] ① Prepare hyaluronic acid solution. Dissolve 60 mg of hyaluronic acid in water at 80°C to prepare a hyaluronic acid solution with a concentration of 15 mg / mL. Heat to dissolve and then perform vacuum drying and degassing (0.1 kPa, 25°C); cool to 25°C, add 120 mg of collagen and dissolve it in water to prepare a collagen solution with a concentration of 30 mg / mL, and perform vacuum drying and degassing (0.1 kPa, 25°C) to obtain a microneedle raw material solution.

[0085] ② Add the above-mentioned microneedle raw material liquid into the microneedle mold, vacuum dry and degas at -20°C, cure for 5 hours, and demold to obtain the collagen microneedle body.

[0086] Wool keratin extraction

[0087] ① Weigh 10g of alpaca wool, soak it in acetone for 24 hours, and then in ethanol for 48 hours to remove grease. After treatment, wash the alpaca wool with deionized water.

[0088] ② Place the treated alpaca wool in a reaction solution, which is 54.2 g urea, 4.75 g SDS, and 2.18 g DTT in 150 mL deionized water, and heat the solution to 60°C for 12 hours. Filter the solution after the reaction, dialyze the filtrate in water for 72 hours, and freeze-dry to collect the wool keratin.

[0089] (IV) Preparation of microneedle upper layer

[0090] ① Add 0.04 g of ferroferric oxide particles into 4 mL of water at 0.01 wt% to prepare a suspension, add 40 mg of wool keratin (concentration of 10 mg / mL) into the suspension, and perform ultrasound to fully disperse the ferroferric oxide particles.

[0091] ② Add 60 mg of hyaluronic acid (concentration of 15 mg / mL) and 120 mg of collagen (concentration of 30 mg / mL) to the aqueous solution of wool keratin containing ferrosoferric oxide particles. Pour the mixed reaction solution into a flat mold, vacuum dry and degas (0.1 kPa, -20°C), cure for 5 hours, and demold to obtain the microneedle upper structure.

[0092] (V) Microneedle Assembly

[0093] The microneedle body is assembled with the microneedle upper layer, and a small amount of water is added to moisten the interface to obtain the microneedle material. Implementation Example 2 :This embodiment provides a near-infrared responsive self-heating microneedle based on recombinant human collagen and a preparation method thereof

[0094] (I) Preparation method of recombinant human collagen

[0095] ① Obtaining the amino acid sequence of recombinant human collagen, the sequence is obtained by splicing the active sequence in type III collagen, and the amino acid sequence is shown in SEQ ID NO: 1;

[0096] ② The pet28a-rCol plasmid with the target amino acid sequence (SEQ ID NO: 1) was transformed into E. coli BL21 competent cells to prepare BL21 / pet28a-rCol strain seed solution, which was inoculated in a fermenter, induced, and fermented to obtain a fermentation broth. The cells were collected, crushed by high-pressure homogenization, and centrifuged to obtain the cell supernatant. The target protein was purified by nickel ion affinity chromatography.

[0097] (II) Preparation of microneedle body

[0098] ① Prepare hyaluronic acid solution. Dissolve 60 mg of hyaluronic acid in water at 80°C to prepare a hyaluronic acid solution with a concentration of 15 mg / mL. Heat to dissolve and then perform vacuum drying and degassing (0.1 kPa, 25°C); cool to 25°C, add 80 mg of collagen and dissolve it in water to prepare a collagen solution with a concentration of 20 mg / mL, and perform vacuum drying and degassing (0.1 kPa, 25°C) to obtain a microneedle raw material solution.

[0099] ② Add the above-mentioned microneedle raw material liquid into the microneedle mold, vacuum dry and degas at -20°C, cure for 5 hours, and demold to obtain the collagen microneedle body.

[0100] Wool keratin extraction

[0101] ① Weigh 10g of alpaca wool, soak it in acetone for 24 hours, and then in ethanol for 48 hours to remove grease. After treatment, wash the alpaca wool with deionized water.

[0102] ② Place the treated alpaca wool in a reaction solution, which is 54.2 g urea, 4.75 g SDS, and 2.18 g DTT in 150 mL deionized water, and heat the solution to 60°C for 12 hours. Filter the solution after the reaction, dialyze the filtrate in water for 72 hours, and freeze-dry to collect the wool keratin.

[0103] (IV) Preparation of microneedle upper layer

[0104] ① Add 0.04 g of ferroferric oxide particles into 4 mL of water at 0.01 wt% to prepare a suspension, add 40 mg of wool keratin (concentration of 10 mg / mL) into the suspension, and perform ultrasound to fully disperse the ferroferric oxide particles.

[0105] ② Add 60 mg of hyaluronic acid (concentration of 15 mg / mL) and 80 mg of collagen (concentration of 20 mg / mL) to 4 mL of aqueous solution of wool keratin containing ferrosoferric oxide particles. Pour the mixed reaction solution into a flat mold, vacuum dry and degas (0.1 kPa, -20°C), cure for 5 hours, and demold to obtain the microneedle upper structure.

[0106] (V) Microneedle Assembly

[0107] The microneedle body is assembled with the microneedle upper layer, and a small amount of water is added to moisten the interface to obtain the microneedle material.

[0108] Example 3 :This embodiment provides a near-infrared responsive self-heating microneedle based on recombinant human collagen and a preparation method thereof

[0109] (I) Preparation method of recombinant human collagen

[0110] ① Obtaining the amino acid sequence of recombinant human collagen, the sequence is obtained by splicing the active sequence in type III collagen, and the amino acid sequence is shown in SEQ ID NO: 1;

[0111] ② The pet28a-rCol plasmid with the target amino acid sequence (SEQ ID NO: 1) was transformed into E. coli BL21 competent cells to prepare BL21 / pet28a-rCol strain seed solution, which was inoculated in a fermenter, induced, and fermented to obtain a fermentation broth. The cells were collected, crushed by high-pressure homogenization, and centrifuged to obtain the cell supernatant. The target protein was purified by nickel ion affinity chromatography.

[0112] (II) Preparation of microneedle body

[0113] ① Prepare hyaluronic acid solution. Dissolve 60 mg of hyaluronic acid in water at 80°C to prepare a hyaluronic acid solution with a concentration of 15 mg / mL. Heat to dissolve and then perform vacuum drying and degassing (0.1 kPa, 25°C); cool to 25°C, add 40 mg of collagen and dissolve in water to prepare a collagen solution with a concentration of 10 mg / mL, and perform vacuum drying and degassing (0.1 kPa, 25°C) to obtain a microneedle raw material solution.

[0114] ② Add the above-mentioned microneedle raw material liquid into the microneedle mold, vacuum dry and degas at -20°C, cure for 5 hours, and demold to obtain the collagen microneedle body.

[0115] Wool keratin extraction

[0116] ① Weigh 10g of alpaca wool, soak it in acetone for 24 hours, and then in ethanol for 48 hours to remove grease. After treatment, wash the alpaca wool with deionized water.

[0117] ② Place the treated alpaca wool in a reaction solution, which is 54.2 g urea, 4.75 g SDS, and 2.18 g DTT in 150 mL deionized water, and heat the solution to 60°C for 12 hours. Filter the solution after the reaction, dialyze the filtrate in water for 72 hours, and freeze-dry to collect the wool keratin.

[0118] (IV) Preparation of microneedle upper layer

[0119] ① Add 0.04 g of ferroferric oxide particles into 4 mL of water at 0.01 wt% to prepare a suspension, add 40 mg of wool keratin (concentration of 10 mg / mL) into the suspension, and perform ultrasound to fully disperse the ferroferric oxide particles.

[0120] ② Add 60 mg of hyaluronic acid (concentration of 15 mg / mL) and 40 mg of collagen (concentration of 10 mg / mL) to 4 mL of an aqueous solution of wool keratin containing ferrosoferric oxide particles. Pour the mixed reaction solution into a flat mold, vacuum dry and degas (0.1 kPa, -20°C), cure for 5 hours, and demold to obtain the microneedle upper structure.

[0121] (V) Microneedle Assembly

[0122] The microneedle body is assembled with the microneedle upper layer, and a small amount of water is added to moisten the interface to obtain the microneedle material.

[0123] Test Example 1 :This test example provides the mechanical properties characterization of the near-infrared responsive self-heating microneedles based on recombinant human collagen prepared in Examples 1 to 3 - compression test

[0124] Experimental procedure: The mechanical properties of the microneedles were determined by pressing a stainless steel plate onto the microneedles using a 100N compression load cell on an MTS E44 universal testing machine.

[0125] When the upper plate initially contacts the microneedle tip, the distance between the upper and lower plates is zero. The lower plate is moved upward to the microneedle patch at a constant speed of 0.1 mm / min until the needles bend and break, at which point the compressive force is recorded.

[0126] like Figure 2 As shown, when the collagen concentration is 10 mg / mL, the maximum force of a single needle is 0.39 N; when the collagen concentration is 20 mg / mL, the maximum force of a single needle is 0.49 N; when the collagen concentration is 30 mg / mL, the mechanical properties of the microneedle are the best, and the maximum force of a single needle is 0.59 N, which can meet the needs of piercing the skin.

[0127] Test Example 2 This test example provides a swelling test in PBS of the near-infrared responsive self-heating microneedles based on recombinant human collagen prepared in Examples 1 to 3.

[0128] Experimental process: In this test example, the swelling test of the microneedles was performed by immersing the microneedles in a 25°C PBS solution for 6h, 12h, 24h, or 48h, then weighing the microneedles and comparing the weight of the microneedles before immersion to calculate the swelling coefficient.

[0129] like Figure 3 As shown, the higher the collagen concentration, the lower the swelling coefficient of the needle in PBS and the stronger the material stability.

[0130] Test Example 3 :This test example provides an L929 cell proliferation test based on the extract of recombinant human collagen near-infrared responsive self-heating microneedles prepared in Example 1

[0131] Experimental procedure: L929 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v / v) fetal bovine serum (FBS, Hyclone, South Logan, UT) and maintained at 37°C in a 5% CO2 atmosphere. The coarse microneedles were extracted with DMEM containing 10% FBS at 4°C for 7 days. L929 cells were seeded in 48-well culture plates at 2×10 4 Cells were cultured at 37°C, 5% CO2 for 24h and 48h, and 500μL of microneedle extract was added to each well. Cells seeded on plates of fresh DMEM supplemented with 10% FBS were used as positive controls. Cell proliferation rate was evaluated by CCK-8 assay. After 24h and 48h, CCK-8 solution was added to the culture medium and incubated for 2h. The absorbance of the culture medium at 450nm was recorded using a Spark 10M microplate reader (Tecan, Switzerland).

[0132] like Figure 4 As shown in the figure, microneedles composed of collagen and hyaluronic acid (MN treated) can effectively promote cell proliferation. The material has good biocompatibility and bioactivity.

[0133] Test Example 4 :This test example provides a comparative experiment of the skin Masson staining results of the near-infrared responsive self-heating microneedle treated with recombinant human collagen prepared in Example 1

[0134] Masson staining process: The samples were treated with xylene I for 5 minutes, xylene II for 5 minutes, xylene III for 5 minutes, anhydrous ethanol for 1 minute, 95% ethanol for 1 minute, and 75% ethanol for 1 minute, followed by tap water rinse for a few seconds and dewaxing to water. Stain with prepared Weigert iron hematoxylin staining solution for 8 minutes. Differentiate with acidic ethanol differentiation solution for 15 seconds and wash with water. De-blue with Masson blue solution for 5 minutes, wash with water, wash with distilled water for 1 minute, stain with Ponceau fuchsin staining solution for 5 minutes, wash with weak acid working solution for 1 minute, wash with phosphomolybdic acid solution for 1 minute, wash with weak acid working solution for 1 minute, stain with aniline blue staining solution for 2 minutes, and wash with weak acid for 1 minute. Finally, dehydrate and make it transparent, use 95% ethanol for rapid dehydration for 2-3 seconds, dehydrate with anhydrous ethanol 3 times, each time for 5-10 seconds, xylene transparent 3 times, each time for 1-2 minutes, and seal with neutral gum.

[0135] like Figure 5 As shown in the figure, compared with the control group, the microneedle treatment group had more collagen content, and the material was conducive to collagen deposition. The microneedle treatment group with added ferric oxide (MN treated-with Fe3O4) had a higher collagen content than the microneedle treatment group without ferric oxide (MN treated-without Fe3O4), indicating that ferric oxide can promote collagen deposition.

[0136] Amino acid sequence of recombinant human collagen (SEQ ID NO: 1):

[0137] MGSSHHHHHHSSGENLYFQGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGL

[0138] PGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGER

[0139] GFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERG

[0140] ERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGRPGERGL

[0141] PGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGGENGM

[0142] PGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGV

[0143] MGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPGK

[0144] PGEPGPKGRPGERGLPGENGGMPGERGVMGFPGKPGEPGPKGERGDLGPQGIAGQRGVVGLPGQRGERGFPGER

[0145] GERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDL

[0146] GPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAG

[0147] QRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVGLPGQRGERGFPGERGERGDLGPQGIAGQRGVVG

[0148] LPGQRGERGFPGERGRPGERGLPGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPG

[0149] KPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPG

[0150] PKGRPGERGLPGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPGPKGRPG

[0151] ERGLPGENGMPGERGVMGFPGKPGEPGPKGRPGERGLPGENGMPGERGVMGFPGKPGEPGPK

[0152] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A near-infrared responsive self-heating microneedle based on recombinant human collagen, characterized in that: It comprises recombinant human collagen and hyaluronic acid; the amino acid sequence of the recombinant human collagen is shown in SEQ ID NO:

1.

2. The near-infrared responsive self-heating microneedle based on recombinant human collagen according to claim 1, characterized in that: The microneedle comprises a microneedle upper structure and a needle body as a microneedle upper support layer; the materials involved in the needle body include recombinant human collagen and hyaluronic acid; the materials involved in the microneedle upper structure include ferroferric oxide and wool keratin.

3. The near-infrared responsive self-heating microneedle based on recombinant human collagen according to claim 1, characterized in that: The preparation method of the recombinant human collagen comprises: transforming the pet28a-rCol plasmid carrying the amino acid sequence of the recombinant human collagen into E. coli BL21 competent cells, preparing BL21 / pet28a-rCol strain seed liquid, inoculating in a fermenter, inducing, and fermenting to obtain fermentation liquid; collecting bacterial cells, high-pressure homogenization and crushing, and centrifuging to obtain bacterial supernatant; and purifying by nickel ion affinity chromatography to obtain the target protein.

4. A method for preparing near-infrared responsive self-heating microneedles based on recombinant human collagen as claimed in any one of claims 1 to 3, characterized in that: The specific steps include: S1, mixing the hyaluronic acid solution and the recombinant human collagen solution to prepare a microneedle raw material solution; S2, adding the microneedle raw material liquid into the mold, and performing vacuum drying, degassing, curing, and demolding to obtain the needle body; S3, adding alpaca wool to an aqueous solution containing urea, sodium lauryl sulfate and dithiothreitol, and heating the solution to obtain wool keratin; S4, adding wool keratin, hyaluronic acid and recombinant human collagen to the aqueous solution containing ferroferric oxide particles, adding the mixed reaction solution to the mold, and performing vacuum drying, degassing, curing and demolding to obtain the microneedle upper structure; S5. Assemble the needle body and the microneedle upper structure together to obtain the microneedle material.

5. The preparation method according to claim 4, characterized in that: In step S1, the mass ratio of hyaluronic acid to recombinant human collagen is 1:1 to 1:3; The concentration of the hyaluronic acid solution is 10-15 mg / mL, and the concentration of the recombinant human collagen solution is 10-30 mg / mL; preferably, the concentration of the hyaluronic acid solution is 15 mg / mL; Preferably, the mixing method is: first prepare a hyaluronic acid solution and heat it at 65°C to 85°C to dissolve it, then perform vacuum drying and degassing treatment, wait until the temperature drops to 20°C to 30°C, add recombinant human collagen solution, perform vacuum drying and degassing treatment, and obtain a microneedle raw material solution; further preferably, the pressure of the vacuum drying and degassing treatment is 0.1 kPa and the temperature is 25°C.

6. The preparation method according to claim 4, characterized in that: Preferably, in step S2, the pressure of the vacuum drying and degassing is 0.08 to 0.15 kPa, and the temperature is -15 to -25°C; preferably, the pressure of the vacuum drying and degassing is 0.1 kPa, and the temperature is -20°C; Preferably, the curing temperature is -15 to -25°C and the curing time is 4 to 6 hours; further preferably, the curing temperature is -20°C and the curing time is 5 hours.

7. The preparation method according to claim 4, characterized in that: In step S3, the mass ratio of urea, sodium dodecyl sulfate and dithiothreitol is 22-25:1.9-2.5:0.8-1.2; preferably, the mass ratio of urea, sodium dodecyl sulfate and dithiothreitol is 24.9:2.2:1; Preferably, the alpaca wool is added thereto after being treated with an organic solvent, and the specific operation is: firstly soak the alpaca wool in acetone for 15 to 24 hours, then treat it with ethanol for 24 to 48 hours to remove grease, and then wash it with deionized water.

8. The preparation method according to claim 4, characterized in that: In step S3, the temperature of the heating reaction is 50-70°C and the time is 8-15 hours; preferably, the temperature of the heating reaction is 60°C and the time is 12 hours; the solution after the heating reaction is filtered, the filtrate is dialyzed in water for 60-72 hours, and the wool keratin is collected by freeze-drying.

9. The preparation method according to claim 4, characterized in that: In step S4, the ferrosoferric oxide particles are added to water at 0.01 wt% to prepare a suspension; the mass volume ratio of the suspension to the wool keratin is 1 mL:10 mg; Preferably, the pressure of the vacuum drying and degassing is 0.08 to 0.15 kPa, and the temperature is -15 to -25°C; further preferably, the pressure of the vacuum drying and degassing is 0.1 kPa, and the temperature is -20°C; Preferably, the curing temperature is -15 to -25°C and the curing time is 4 to 6 hours; more preferably, the curing temperature is -20°C and the curing time is 5 hours; Preferably, in step S5, during the bonding and assembly, a small amount of water is added to moisten the interface to ensure a close fit.

10. Use of the near-infrared responsive self-heating microneedle based on recombinant human collagen as described in any one of claims 1 to 3 in the preparation of beauty and skin care products, pharmaceutical products, and medical device products.